COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 456: Articles 4551-4560  | Next

Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infection
Lu, M., Yao, W., Li, Y., Ma, D., Zhang, Z., Wang, H., Tang, X., Wang, Y., Li, C., Cheng, D., Lin, H., Yin, Y., Zhao, J., Zhong, G.
10.1101/2023.02.22.529625 — Posted: 2023-02-23
Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo
Mei, Y.-F., Zhang, Q., Hammond, M. E., Song, J., Fang, Z., Zhao, H., Landstrom, M.
10.1101/2023.02.23.529497 — Posted: 2023-02-23
Characteristics and Outcomes of Multisystem Inflammatory Syndrome in Children: A Multicenter, Retrospective, Observational Cohort Study in Mexico
Gonzalez-Garcia, N., Yamazaki-Nakashimada, M. A., Marquez-Gonzalez, H., Miranda-Novales, G., Neme Diaz, G. A., Prado Duran, S. A., Luevanos Velazquez, A., CASTILLA PEON, M. F., Sanchez Duran, M. A., Marquez Aguirre, M. P., Villasis-Keever, M. A., Aragon Nogales, R., Nunez Enriquez, C., Martinez Bustamante, M. E., Palacios Cantu, L. A., Membrila Mondragon, J., Vizcarra Alvarado, P., Jimenez Juarez, R. N., Olivar Lopez, V., Lopez Chavez, A., Perez Barrera, A., Aguilar Arguello, C., Ramirez de los Santos, J.
10.1101/2023.02.16.23285979 — Posted: 2023-02-23
SARS-CoV2 mRNA-vaccination-induced Immunological Memory in Human Non-Lymphoid and Lymphoid Tissues
Pross, V., Sattler, A., Lukassen, S., Toth, L., Thole, L. M. L., Siegle, J., Stahl, C., He, A., Damm, G., Seehofer, D., Goetz, C., Bayerl, C., Jaeger, P., Macke, A., Eggeling, S., Kirzinger, B., Mayr, T., Herbst, H., Bayer, K., Laue, D., Kroenke, J., Braune, J., Rosseck, F., Friedersdorff, F., Hubatsch, M., Weinberger, S., Lachmann, N., Hofmann, V., Schrezenmeier, E., Ludwig, C., Schrezenmeier, H., Jechow, K., Conrad, C., Kotsch, K.
10.1101/2023.02.22.23286293 — Posted: 2023-02-23
Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases
Crone, M. A., Hakki, S., Zhou, J., Rosadas de Oliveira, C., Madon, K. J., Koycheva, A. V., Badhan, A., Jonnerby, J., Fenn, J., Kundu, R., Barnett, J. L., Nevin, S., Conibear, E., Derqui-Fernandez, N., Pillay, T. D., Varro, R., Luca, C., Quinn, V., Shazaad, A., Zambon, M., Barclay, W., Dunning, J., Freemont, P. S., Taylor, G. P., Lalvani, A.
10.1101/2023.02.15.23285923 — Posted: 2023-02-23
Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program
Varma, J. K., Zang, C., Carton, T. W., Block, J. P., Khullar, D. J., Zhang, Y., Weiner, M. G., Rothman, R. L., Schenck, E. J., Xu, Z., Lyman, K., Bian, J., Shenkman, E., Maughan, C., Castro-Baucom, L., OBrien, L., Wang, F., Kaushal, R.
10.1101/2023.02.15.23286012 — Posted: 2023-02-23
BRIEF COMMUNICATION High level of Anti SARS-Co-V2 RBD Antibody one year post booster vaccine hospital workers in Indonesia; Was second booster needed?
Muslimah, A. H., Tiara, M. R., Djauhari, H., Dewantara, H., Susandi, E., Indrati, A. R., Soeroto, A. Y., Alisjahbana, B., Wisaksana, R.
10.1101/2023.02.15.23285958 — Posted: 2023-02-23
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern.
Vikstrom, L., Fjallstrom, P., Gwon, Y.-D., Sheward, D. J., Wigren-Bystrom, J., Evander, M., Bladh, O., Widerstroem, M., Molnar, C., Rasmussen, G., Bennet, L., Aberg, M., Bjork, J., Tevell, S., Thalin, C., Blom, K., Klingstrom, J., Murrell, B., Ahlm, C., Normark, J., Johansson, A. F., Forsell, M.
10.1101/2023.02.16.23286009 — Posted: 2023-02-23
Has the COVID-19 pandemic ended or not? opinions from the public in the U.S.
Yang, Y.
10.1101/2023.02.15.23285880 — Posted: 2023-02-23
Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 Applications
Xiong, J.
10.1101/2023.02.21.527754 — Posted: 2023-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).